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Although clinical nutrition is a frequently used intervention in inpatient care, high quality trials proving its effectiveness
and safety when used in the acutely-ill polymorbid medical inpatient population are largely lacking. From an
evolutionary perspective, illness-related low appetite is protective and part of the host response to improve
recovery from disease. Large and well performed trials in the intensive care setting have shown deleterious
effects of (parenteral) feeding strategies aiming at higher caloric intakes compared to lower intakes, raising the
question of whether feeding per se may be simply maladaptive in acute severe illness. Outside critical care,
similar large-scale studies are lacking with basic clinical questions regarding the optimal amount/composition of
nutrition and best patient selection remaining largely unanswered. Also, the interplay of nutritional interventions
and its influence on the microbiome remains largely unclear. Given the magnitude of morbidity caused by
malnutrition and the high number of affected patients, it is surprising how little the medical community has
invested in better understanding ways to improve this condition. It is now time to perform high-quality trials to
better understand how to best deal with this condition in the acute care setting. Such trials will allow change
from a one-size-fits-all approach, to more evidence-based, personalized nutritional interventions, ultimately
improving patient outcomes. While there is ongoing discussion about definition of malnutrition, we should
rather focus on the identification of patients who do or do not benefit from nutritional interventions.
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Background
Nutritional research experienced a very promising
start in 1747 with James Lind conducting the first ever
randomized controlled trial comparing six different
treatments for 12 sailors with scurvy [1]. Hippocrates,
himself, had great hopes for nutritional interventions
to cure disease (“Let food be thy medicine and medicine be
thy food”). Today, however, there are few rigorously
conducted trials of nutritional interventions that assess
their impact on mortality, morbidity, or other patient-
centered outcomes. This is particularly true for the
acute, non-critical medical care inpatient setting, where
there is an important lack of studies to guide clinicians
in the optimal use of nutrition in an “evidence-based”
manner and help us understand the potential of nutrition
to cure disease, or at least to improve patient out-
comes [2].
Nutritional therapy
Regarding the question of nutrition for primary preven-
tion of disease, several large randomized trials have
demonstrated impact on mortality and morbidity. For
example, the PREDIMED trial showed the positive ef-
fects of a Mediterranean diet on cardiovascular and
metabolic disease [3]. Additionally, several recent large
trials have had an important impact on today’s manage-
ment of patients in the critical care setting [4–6].
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Within this population, if insufficient nutritional sup-
port is provided, patients will accumulate a large energy
deficit that may contribute to lean-tissue wasting,
which is associated with adverse outcomes. Yet, sur-
prisingly, recent evidence has pointed to detrimental
effects of feeding strategies in the setting of critical ill-
ness, with possible negative effects on cell recycling
(autophagy) and an increase in morbidity and mortality
[4]. Further, worse outcomes due to refeeding associ-
ated with early feeding have also been reported [7].
These trials challenge our understanding of “physio-
logical nutrition” in the context of severe illness. Thus,
recent recommendations based on these trials suggest a
hypocaloric macronutrient intake during the first week
of critical illness and a continuous increase once the
patient’s condition has stabilized [5].
Evidence from critical care studies showing harmful
effects when clinical nutrition is used [4, 6] highlights
the unanswered questions regarding whether acutely ill,
malnourished inpatients benefit at all from nutritional
support or, conversely, whether loss of appetite should
be viewed as a protective physiological response. In
fact, feeding in acute severe illness may be simply mal-
adaptive. While observational research has reported
strong associations of malnutrition and adverse out-
comes, and suggested benefit from nutritional interven-
tion in the medical inpatient setting, only randomized
trials can prove that such interventions truly work. A
recent meta-analysis focusing on randomized trials in
the medical inpatient setting that compared patients
receiving nutritional interventions with patients not re-
ceiving such an intervention found that nutritional
therapy increases caloric and protein intake, as well as
weight [8]. Regarding clinical outcomes, unplanned
hospital readmission rates were significantly improved
by the intervention, as well as lengths of stay in the
subgroup of patients with established malnutrition.
However, no effects were found on functional out-
comes, infection risk, or mortality – arguably the most
important outcomes. Importantly, this meta-analysis
also pointed out the low quality of most of the 22
included trials (with a total of 3736 participants), with
high heterogeneity across trials and an overall unclear
risk of bias. Thus, the lack of significant results regard-
ing mortality and morbidity may be due to methodo-
logical issues and low statistical power, and not due to
a lack of effectiveness. Indeed, since the publication of
this meta-analysis, the large-scale, multicenter, placebo-
controlled, interventional NOURISH trial including
older malnourished adults hospitalized for congestive
heart failure, acute myocardial infarction, pneumonia, or
chronic obstructive pulmonary disease was published, that
found a significant lower mortality in patients when a
high-protein oral nutritional supplement containing beta-
hydroxy-beta-methylbutyrate was added to standard-of-
nutritional-care [9].
Remarkably, therefore, basic questions such as, “What
is the optimal amount of calories and protein for med-
ical inpatients?”; “Which medical inpatients have the
most benefit from nutritional interventions?”; and
“What type of nutrition (if any) is beneficial for the
medical inpatient?” remain largely unanswered [10].
Further, from an evolutionary perspective, it remains
unclear whether nutritional interventions should indeed
be used in patients with a functional gastrointestinal
tract and low appetite. The loss of appetite associated
with severe disease may in fact be a protective, physio-
logical response and not a therapeutic target that can
be positively influenced by nutritional interventions
[11]. Instead of continuing to use nutritional therapy in
the acute care setting based on a “gut-feeling” and on
results from mainly observational and smaller random-
ized, hypothesis-generating studies, we should now take
a step back and conduct high quality, randomized con-
trolled trials that will aid the understanding of what, if
anything, constitutes evidence-based nutritional ther-
apy in specific hospitalized populations [2]. While there
is ongoing discussion about the best definitions of
malnutrition [12], we should rather focus on the identi-
fication of patients who do or do not benefit from
nutritional interventions. Specific biomarkers may be
helpful to select populations in which nutritional inter-
ventions will have the best effects and those which
would experience negative outcomes [13].
In the acute care medical setting – outside critical care
– malnutrition remains an increasing problem, affecting
as much as 30–50% of patients [14]. Undoubtedly, there
is a strong association between malnutrition and adverse
clinical outcomes, including higher mortality and mor-
bidity and increased lengths of hospital stay [14]. These
associations tempt us to believe that improvement in
nutritional status by the use of nutritional interventions
also leads to improvements in patient outcomes. How-
ever, similar findings have been reported for nutritional
factors, such as vitamin D, where associations suggested
harmful effects, but intervention research failed to find
benefit [15, 16]. Still, from a pragmatic standpoint, des-
pite having few rigorously designed nutritional interven-
tion trials in acute care patients, there remain several
reasons to support the current approach of systematic-
ally screening inpatients for malnutrition and commen-
cing nutritional therapy in those identified. First, an
inadequate dietary intake leads to dysfunction of the
immune system and mucosal damage in the gut, which
increases the risk for diarrhea, malabsorption, bacterial
invasion (translocation), and infections [11]. Second,
malnutrition is associated with adverse metabolic conse-
quences, such as catabolism and muscle wasting, and
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epidemiological studies from various countries and
healthcare settings have shown strong associations of
malnutrition and adverse patient outcomes. Third, a
retrospective analysis of controlled trials found positive
effects of nutritional support if patients had either
impaired nutritional status or an increase in nutritional
requirements resulting from high severity disease, or
both [17]. Fourth, the above mentioned meta-analysis
[8], as well as the very recent NOURISH trial [9], found
some positive effects of nutritional support on readmission
and mortality in medical inpatients.
Conclusions
Despite strong associations between malnutrition and
adverse outcomes, causal inferences remain largely un-
proven. Additionally, whether provision of nutritional
therapy in the acute phase of a medical illness has the
potential to reverse the adverse effects associated with
malnutrition in the non-critical care inpatient setting re-
mains unclear. Given the magnitude of morbidity caused
by malnutrition and the high number of patients affected
by this condition, it is surprising how little the medical
community has invested in recent years to better under-
stand ways to improve this condition in an “evidence-
based” manner. Although the use of nutritional therapy
is a common intervention in medical inpatients, there is
no strong current scientific evidence of its efficacy or
standard algorithms for its use in medical inpatients.
This may be explained by difficulties in standardization,
blinding, and patient compliance in nutritional trials,
and insufficient industry-funding due to low product
margins, among other issues [18]. Still, considering
recent high-quality evidence from critical care demon-
strating the negative effects of nutritional therapy, a
reappraisal of how nutritional support should be imple-
mented in the medical inpatient setting is now re-
quired. The selection, timing, dose and feasibility of
nutritional treatment should be evaluated as carefully
as with any other therapeutic interventions, with the
aim of maximizing efficacy and minimizing side effects
and costs. Further, trials should investigate the effects
of nutritional interventions on the microbiome, which
may play a key role in this issue. Instead of pragmatic-
ally using nutritional interventions based on few rigor-
ous randomized trials, we should return to James Lind’s
research of 1747 and perform the large and well con-
ducted trials needed to truly understand the potential
of nutritional therapy to positively influence recovery
from disease in the medical inpatient population.
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